No Detail Found!

Effects of atorvastatin and Zishen Qingqi granules on immune function and liver function of patients with systemic lupus erythematosus with mild and moderate activity

Author(s)
Yuzi Sun Department of Pharmacy,Zhangqiu District People's Hospita, Jinan City,Shandong Province, China
Lili Yuan Department of Nephrology, YanTai Penglai Traditional Chinese Medical Hospital, Yantai City, Shandong Province, China
Xinrui Liu Intravenous Medicine Blending Center,Zhangqiu District People's Hospita, Jinan City, Shandong Province, China
Wenjuan Yu Intravenous Medicine Blending Center,Zhangqiu District People's Hospita, Jinan City, Shandong Province,China
Jie Li Intravenous Medicine Blending Center,Zhangqiu District People's Hospita, Jinan City, Shandong Province, China
Abstract
To explore the effect of atorvastatin combined with Zishen Qingqi Granules on the immune function and liver function of patients with mild to moderate activity systemic lupus erythematosus. The data of 120 patients with mild to moderate activity systemic lupus erythematosus admitted to our hospital from February 2019 to February 2020 were retrospectively analyzed and they were divided into experimental group (n=60) and the control group (n=60) according to the order of admission; the control group was treated with atorvastatin, and the experimental group was treated with Zishen Qingqi Granules plus. The immune function, liver function, TCM syndrome score and systemic lupus erythematosus disease activity index (SLEDAI) were compared between the two groups. The experimental group after treatment was superior to the control group with respect to immune function indexes, liver function indexes, SLEDAI and TCM syndromes (all P<0.001). Atorvastatin combined with Zishen Qingqi Granules can improve the liver function of patients with mild to moderate activity systemic lupus erythematosus, enhance their immunity, and relieve their clinical symptoms.
Publication Details
Page(s) 931-936
Published Journal: Unknown journal, Volume: 35, Issue: S3, Year: 2022

Request the full text from PASTIC

Keywords
Systemic lupus erythematosus, Zishen Qingqi granules, Atorvastatin
References
Beqiri E,Czosnyka M,Lalou AD,Zeiler FA,Fedriga M,Steiner LA,Chieregato A,Smielewski P .2020 .Influence of mild-moderate hypocapnia on intracranial pressure slow waves activity in TBI. Acta Neurochir (Wien), 162(162) : 345-356.
Fei ZW,Zhang XP,Zhang J,Huang XM,Wu DJ,Bi HH .2016 .Protective effects of Radix Astragali injection on multiple organs of rats with obstructive jaundice. Chin. J. Integr Med, 22(22) : 674-684.
Gomes MF,Mardones C,Xipell M,Blasco M,Sole M,Espinosa G,García-Herrera A,Cervera R,Quintana LF .2021 .The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis. J. Nephrol, : .
Hu J,Wang M,Xiao X,Zhang B,Xie Q,Xu X,Li S,Zheng Z,Wei D,Zhang X .2020 .A novel longacting azathioprine polyhydroxyalkanoate nanoparticle enhances treatment efficacy for systemic lupus erythematosus with reduced side effects. , 12(12) : 10799-10808.
Kasturi S,Szymonifka J,Berman JR,Kirou KA,Levine AB,Sammaritano LR,Mandl LA .2020 .Responsiveness of the patient-reported outcomes measurement information system global health short form in outpatients with systemic lupus erythematosus. Arthritis Care Res (Hoboken), 72(72) : 1282-1288.
Kumar A,Singh MB,Garg A,Vishnu VY .2021 .Systemic lupus erythematosus presenting with holocord myelitis. J. Postgrad Med, 67(67) : 33-35.
Lim SY,Bae EH,Han KD,Jung JH,Choi HS,Kim CS,Ma SK,Kim SW SK .2019 .Systemic lupus erythematosus is a risk factor for atrial fibrillation: A nationwide, population-based study. Clin Exp Rheumatol, 37(37) : 1019-1025.
Meyer A,Guffroy A,Blaison G,Dieudonne Y,Amoura Z,Bonnotte B,Fiehn C,Kieffer P,Lorenz HM,MagyBertrand N,Maurier F,Pennaforte JL,Peter HH,Schwarting A,Sibilia J,Arnaud L,Martin T,Voll RE,Korganow AS .2020 .Systemic lupus erythematosus and neutropaenia: A hallmark of haematological manifestations. Lupus Sci. Med, 7(1) : e000399.
Nichilatti LP,Fernandes JM,Marques CP JM .2020 .Physiopathology of pain in systemic erythematosus lupus. , 29(29) : 721-726.
Nishino A,Katsumata Y,Kawasumi H,Hirahara S,Kawaguchi Y,Yamanaka H Y .2019 .Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus. , 28(28) : 986-994.
Petri M .2020 .Pregnancy and systemic lupus erythematosus. Best Pract. Res. Clin. Obstet Gynaecol, 64(64) : 24-30.
Seridi L,Cesaroni M,Orillion A,Schreiter J,Chevrier M,Marciniak S,Migone TS,Stohl W,Chatham WW,Furie RA,Benson J,Jordan J .2021 .Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition. , 30(30) : 795-806.
Shi Y,Li M,Liu L,Wang Z,Wang Y,Zhao J,Wang Q,Tian X,Li M,Zeng X .2021 .Relationship between disease activity, organ damage and healthrelated quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis. Autoimmun. Rev., 20(20) : 102691.
Shovman O,Tamar S,Amital H,Watad A,Shoenfeld Y .2018 .Diverse patterns of anti-TNF-α-induced lupus: Case series and review of the literature. Clin. Rheumatol, 37(37) : 563-568.
Solomon-Moore E,Jago R,Beasant L,Brigden A,Crawley E .2019 .Physical activity patterns among children and adolescents with mild-to-moderate chronic fatigue syndrome/myalgic encephalomyelitis. , 3(3) : e000425.
Wei Z,Zhang Y,Chen Y,Xia X,Zheng B,Sun X,Zhang G,Wang L,Zhang Q,Xu C,Jiang S,Li X,Xie B,Liao X,Ai Z,Li X .2019 .Antiapoptosis effect of ZiShen prescription to increase learning and memory abilities of compound Alzheimer's disease model rats. J. Cell Biochem. Online ahead of print., : .
Xu Y,Baylink DJ,Chen CS,Reeves ME,Xiao J,Lacy C,Lau E,Cao H E .2020 .The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID19. J. Transl Med, 18(18) : 322.
Yao Z,Loggia L,Fink D,Chevrier M,Marciniak S,Sharma A,Xu Z A .2020 .Pharmacokinetics and pharmacodynamics of JNJ-55920839, an antibody targeting interferon α/ω, in healthy subjects and subjects with mild-to-moderate systemic lupus erythematosus. Clin. Drug Investig, 40(40) : 1127-1136.
Zhang M,Qi C,Zha Y,Chen J,Luo P,Wang L,Sun Z,Wan J,Xing C,Wang S,Jiang G,Sun M,Chen Q,Chen J,Li D,Guan T,Ni Z T .2019 .Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: A randomized trial. Clin. Rheumatol, 38(38) : 859-867.
Zhao J,Cheng Q,Liu Y,Yang G,Wang X .2019 .Atorvastatin alleviates early hypertensive renal damage in spontaneously hypertensive rats. Biomed, 109(109) : 602-609.
0

Citations

0

Downloads

10

Views